Surface engineering for efficient capture of circulating tumor cells in renal cell carcinoma: From nanoscale analysis to clinical application

2020 ◽  
Vol 162 ◽  
pp. 112250 ◽  
Author(s):  
Jiyoon Bu ◽  
Ashita Nair ◽  
Luke J. Kubiatowicz ◽  
Michael J. Poellmann ◽  
Woo-jin Jeong ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Clinical Application ◽  
Renal Cell ◽  
Surface Engineering

scholarly journals Prognostic Role of Circulating Tumor Cells ( CTCS ) in Metastatic Renal Cell Carcinoma: A Large, Multicenter Prospective Trial

2021 ◽  
Author(s):  
Umberto Basso ◽  
Antonella Facchinetti ◽  
Elisabetta Rossi ◽  
Marco Maruzzo ◽  
Vincenza Conteduca ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Prospective Trial ◽  
Prognostic Role

scholarly journals Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression

2020 ◽  
Vol 21 (4) ◽  
pp. 1475
Author(s):  
Vera Cappelletti ◽  
Elena Verzoni ◽  
Raffaele Ratta ◽  
Marta Vismara ◽  
Marco Silvestri ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Renal Cell ◽  
Progression Free Survival ◽  
Response Prediction ◽  
Surface Proteins ◽  
Cell Recovery ◽  
Epithelial Cell Surface

Circulating tumor cells (CTCs) are promising biomarkers for prognosis, therapeutic response prediction, and treatment monitoring in cancer patients. Despite its epithelial origin, renal cell carcinoma (RCC) shows low expression of epithelial markers hindering CTC-enrichment approaches exploiting epithelial cell surface proteins. In 21 blood samples serially collected from 10 patients with metastatic RCC entering the TARIBO trial, we overcame this limitation using the marker-independent Parsortix™ approach for CTC-enrichment coupled with positive and negative selection with the DEPArray™ with single cell recovery and analysis for copy number alterations (CNA) by next generation sequencing NGS. Two CTC subpopulations were identified: epithelial CTC (eCTC) and non-conventional CTC (ncCTC) lacking epithelial and leukocyte markers. With a threshold ≥1CTC/10 mL of blood, the positivity rates were 28% for eCTC, 62% for ncCTCs, and 71% considering both CTC types. In two patients with detectable eCTCs at baseline, progression free survival was less than 5 months. In an index case, hierarchical structure by translational oncology (TRONCO) identified three clones among 14 CTCs collected at progression and at baseline, each containing cells with a 9p21.3loss, a well-known metastasis driving subclonal alteration. CTCs detection in RCC can be increased by marker-independent approaches, and CTC molecular characterization can allow detection of subclonal events possibly related to tumor progression.

Abstract 2231: Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis

2010 ◽  
Author(s):  
Steffen Goebel ◽  
Karen Bluemke ◽  
Udo Bilkenroth ◽  
Axel Meye ◽  
Susanne Fuessel ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Peripheral Blood ◽  
Renal Cell

Role of circulating tumor cells in patients with metastatic clear-cell renal cell carcinoma

2020 ◽  
Author(s):  
Brusabhanu Nayak ◽  
Sridhar Panaiyadiyan ◽  
Prabhjot Singh ◽  
Subhradip Karmakar ◽  
Seema Kaushal ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Renal Cell ◽  
Clear Cell ◽  
Cell Renal Cell Carcinoma

scholarly journals Circulating Tumor Cells in Renal Cell Carcinoma: Recent Findings and Future Challenges

2019 ◽  
Vol 9 ◽  
Author(s):  
Matteo Santoni ◽  
Alessia Cimadamore ◽  
Liang Cheng ◽  
Antonio Lopez-Beltran ◽  
Nicola Battelli ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Renal Cell ◽  
Future Challenges

scholarly journals Circulating tumor cells status in metastatic renal cell carcinoma (mRCC) after metastasectomy (RESORT trial)

2015 ◽  
Vol 26 ◽  
pp. vi62
Author(s):  
E. Verzoni ◽  
P. Grassi ◽  
V. Cappelleti ◽  
C. Maggi ◽  
R. Montone ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell

Abstract 368: Detection of circulating tumor cells in peripheral blood of renal cell carcinoma patients is correlated with survival.

2013 ◽  
Author(s):  
Steffen Goebel ◽  
Karen Bluemke ◽  
Udo Bilkenroth ◽  
Axel Meye ◽  
Susanne Fuessel ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Peripheral Blood ◽  
Renal Cell
Sign in / Sign up

Export Citation Format

Share Document